FDA Issues Form 483 to Torrent Pharmaceuticals
Torrent Pharmaceuticals on Wednesday said the US health regulator has issued a Form 483 with five observations after inspecting its Gujarat-based manufacturing plant. The US Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAI) and a GMP inspection at the company's manufacturing facility in Indrad, Gujarat, from June 3 to June 12, the drug firm said in a regulatory filing.
NEW DELHI: Ahmedabad-based Torrent on Wednesday said it has entered into a non-exclusive patent licensing agreement with Takeda Pharma for sale of Vonoprazan in India.
Mankind Pharma, Dr Reddy’s Laboratories and Torrent Pharma are among those that have evinced interest in acquiring JB Chemicals & Pharmaceuticals from KKR, said multiple people aware of the development.
An Indian industrialist wants to buy Biogaran, the French number one in generics
Torrent Pharma`s Generic Doxycycline Hyclate Receives Approval in the U.S.
Torrent Pharma`s Generic Teriflunomide Receives Approval in the U.S.
Torrent Pharma`s Generic Potassium Citrate Receives Approval in the U.S.
Torrent Pharma`s Generic Fluphenazine Hydrochloride Receives Approval in the U.S.